RXST Insider Trading
Insider Ownership Percentage: 9.36%
Insider Buying (Last 12 Months): $549,098.81
Insider Selling (Last 12 Months): $9,651,106.44
RxSight Share Price & Price History
Current Price: $29.81
Price Change: ▼ Price Decrease of -2.06 (-6.46%)
As of 02/14/2025 05:00 PM ET
RxSight Insider Trading History
RxSight Institutional Trading History
Data available starting January 2016
RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Read More on RxSight
Today's Range
Now: $29.81
52 Week Range
Now: $29.81
Volume
597,816 shs
Average Volume
670,931 shs
Market Capitalization
$1.20 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.19
Who are the company insiders with the largest holdings of RxSight?
RxSight's top insider shareholders include:
- Bakker Juliet Tammenoms (Director)
- Ronald M Md Kurtz (CEO)
- Jesse Anderson Corley (Director)
- Eric Weinberg (Insider)
- Ilya Goldshleger (Insider)
- Julie Andrews (Director)
- Robert Keith Warner (Director)
- Ilya Goldshleger (COO)
- Shweta Maniar (Director)
- William J Phd Link (Director)
- Shelley B Thunen (CFO)
Learn More about top insider investors at RxSight.
Who are the major institutional investors of RxSight?
RxSight's top institutional investors include:
- RA Capital Management L.P. — 9.29%
- Vanguard Group Inc. — 5.91%
- Artisan Partners Limited Partnership — 3.85%
- Geode Capital Management LLC — 2.06%
- Gilder Gagnon Howe & Co. LLC — 1.06%
- DF Dent & Co. Inc. — 1.05%
Learn More about top institutional investors of RxSight stock.
Which major investors are selling RxSight stock?
During the previous quarter, RXST stock was sold by these institutional investors:
- Invesco Ltd.
- Next Century Growth Investors LLC
- RA Capital Management L.P.
- Gilder Gagnon Howe & Co. LLC
- JPMorgan Chase & Co.
- American Century Companies Inc.
- Oberweis Asset Management Inc.
- Walleye Capital LLC
In the previous year, company insiders that have sold RxSight company stock include:
- Bakker Juliet Tammenoms (Director)
- Ronald M Md Kurtz (CEO)
- Jesse Anderson Corley (Director)
- Eric Weinberg (Insider)
- Ilya Goldshleger (Insider)
Learn More investors selling RxSight stock.
Which major investors are buying RxSight stock?
In the previous quarter, RXST stock was acquired by institutional investors including:
- DF Dent & Co. Inc.
- Artisan Partners Limited Partnership
- Dimensional Fund Advisors LP
- Schonfeld Strategic Advisors LLC
- Renaissance Technologies LLC
- Altium Capital Management LLC
- Vitruvian Partners LLP
- Thrivent Financial for Lutherans
During the previous year, these company insiders have bought RxSight stock:
- Bakker Juliet Tammenoms (Director)
- Ronald M Md Kurtz (CEO)
Learn More investors buying RxSight stock.